| 321.916.407 € | Execució | SWEDISH ORPHAN BIOVITRUM, SL | 4.747.917 € | 98,5 % | — |
| | UCB PHARMA,S.A. | 1.753.801 € | 99,5 % | |
| | NEOVII PHARMACEUTICALS AG | 38.335 € | 100 % | |
| | MERCK SHARP & DOHME ESPAÑA,SA. | 7.381.226 € | 97,7 % | |
| | ALTAN PHARMACEUTICALS SA | 9.409 € | 100 % | |
| | SANDOZ FARMACEUTICA SA | 7.774 € | 100 % | |
| | NORGINE DE ESPAÑA SL | 695 € | 100 % | |
| | JAZZ PHARMACEUTICALS IBERIA SL | 284.000 € | 99,9 % | |
| | BRISTOL MYERS SQUIBB,S.A. | 3.867.282 € | 98,8 % | |
| | ALMIRALL,S.A. | 331.095 € | 99,9 % | |
| | JANSSEN-CILAG,S.A. | 26.532.984 € | 91,8 % | |
| | TEVA PHARMA, SL | 102.593 € | 100 % | |
| | SANOFI-AVENTIS,S.A. | 10.809.025 € | 96,6 % | |
| | LACER SA | 27.334 € | 100 % | |
| | GLAXOSMITHKLINE, S.A. | 816.921 € | 99,7 % | |
| | CHIESI ESPAÑA SAU | 990.532 € | 99,7 % | |
| | JUSTE FARMA SLU | 50.721 € | 100 % | |
| | KERN PHARMA, S.L. | 24.460 € | 100 % | |
| | MYLAN PHARMACEUTICALS, S.L | 161.445 € | 99,9 % | |
| | LABORATORIOS LEO PHARMA, SA | 11.239 € | 100 % | |
| | BRILL PHARMA SL | 53.601 € | 100 % | |
| | ALFASIGMA ESPAÑA SL | 48.072 € | 100 % | |
| | LABORATORIOS SERRA PAMIES,S.A. | 176 € | 100 % | |
| | NOVARTIS FARMACEUTICA,S.A. | 6.915.202 € | 97,9 % | |
| | INIBSA DENTAL SL. | 2.385 € | 100 % | |
| | LAB. FARMAC. GUERBET, SA. | 1.679 € | 100 % | |
| | B.BRAUN MEDICAL,S.A. | 414.148 € | 99,9 % | |
| | CSL BEHRING,S.A. | 1.716.947 € | 99,5 % | |
| | EUSA PHARMA IBERIA SL | 53.560 € | 100 % | |
| | ADVANZ PHARMA SPAIN SL | 16.107 € | 100 % | |
| | BIOTEST MEDICAL, SLU | 57.867 € | 100 % | |
| | LABORATORIOS GEBRO PHARMA, S.A | 84.835 € | 100 % | |
| | ALEXION PHARMA SPAIN S.L.U. | 5.415.111 € | 98,3 % | |
| | TAKEDA FARMACEUTICA ESPAÑA, SA | 10.010.869 € | 96,9 % | |
| | BAYER HISPANIA, SL | 6.123.020 € | 98,1 % | |
| | BIOMARIN PHARMACEUTICALS ESPAÑA,S.L. | 1.152.270 € | 99,6 % | |
| | BAXTER,S.L. | 750.333 € | 99,8 % | |
| | BAUSCH & LOMB SA | 9.775 € | 100 % | |
| | LABORATORIO STADA,S.L. | 4.212 € | 100 % | |
| | ASTRAZENECA FARMACEUT.SPAIN,SA | 3.013.361 € | 99,1 % | |
| | OPELLA HEALTHCARE SPAIN SLU | 20.932 € | 100 % | |
| | ALNYLAM PHARMACEUTICALS SPAIN SL | 886.845 € | 99,7 % | |
| | IPSEN PHARMA,S.A. | 538.185 € | 99,8 % | |
| | LABORATORIOS FARMACEUTICOS ROVI, SA | 956.601 € | 99,7 % | |
| | BIOGEN SPAIN SL | 7.675.450 € | 97,6 % | |
| | RECORDATI RARE DISEASES SPAIN | 128.854 € | 100 % | |
| | VIFOR PHARMA ESPAÑA, SL | 2.195.827 € | 99,3 % | |
| | VERTEX PHARMACEUTICALS SPAIN SL | 4.619.242 € | 98,6 % | |
| | TILLOTTS PHARMA SPAIN SLU | 97.125 € | 100 % | |
| | PIERRE FABRE IBERICA, SA | 439.020 € | 99,9 % | |
| | LABORATORIOS ERN,S.A. | 4.505 € | 100 % | |
| | KYOWA KIRIN FARMACEUTICA SL | 1.194.593 € | 99,6 % | |
| | AMGEN,S.A. | 3.731.474 € | 98,8 % | |
| | GRIFOLS MOVACO SA | 2.013 € | 100 % | |
| | GE HEALTHCARE BIO-SCIENCES,SA | 100.474 € | 100 % | |
| | PHARMAMAR, S.A. | 236.674 € | 99,9 % | |
| | ROCHE FARMA,S.A. | 15.468.907 € | 95,2 % | |
| | ASTELLAS PHARMA, S.A. | 1.352.295 € | 99,6 % | |
| | NORDIC PHARMA SA | 89.675 € | 100 % | |
| | NOVO NORDISK PHARMA,S.A. | 2.380.365 € | 99,3 % | |
| | MERCK SL | 2.187.366 € | 99,3 % | |
| | GILEAD SCIENCES, S.L. | 17.327.590 € | 94,6 % | |
| | BOEHRINGER INGELHEIM ESPAÑA,SA | 2.940.557 € | 99,1 % | |
| | LABORATORIOS VIIV HEALTHCARE,S.L. | 10.541.441 € | 96,7 % | |
| | FERRING, S.A. | 60.277 € | 100 % | |
| | PFIZER SLU | 6.681.182 € | 97,9 % | |
| | SMITH & NEPHEW,S.A.U. | 46.869 € | 100 % | |
| | LILLY,S.A. | 1.371.665 € | 99,6 % | |
| | LABORATORIOS THEA, S.A. | 23.964 € | 100 % | |
| | CARDIOLINK SL | 194.350 € | 99,9 % | |
| | MEDTRONIC IBERICA,S.A. | 37.485 € | 100 % | |
| | CASEN RECORDATI SL | 17.382 € | 100 % | |
| | FRESENIUS KABI, S.A.U. | 410.196 € | 99,9 % | |
| | ABBVIE SPAIN SL | 2.372.702 € | 99,3 % | |
| | ANGELINI PHARMA ESPAÑA SLU | 266.316 € | 99,9 % | |
| | LAINCO,S.A. | 12.656 € | 100 % | |
| | OCTAPHARMA, S.A. | 278.067 € | 99,9 % | |
| | VIATRIS HEALTHCARE SL | 18.622 € | 100 % | |
| | LABORATORIOS RUBIÓ SA | 344.534 € | 99,9 % | |
| | CELGENE SL | 4.655.680 € | 98,6 % | |
| | LABORATORIO REIG JOFRE SA | 61.146 € | 100 % | |
| | ACCORD HEALTHCARE SLU | 170.681 € | 99,9 % | |
| | BEXAL FARMACEUTICA SA | 12.894 € | 100 % | |
Licit